Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 5569201
- CPT
- -
- Packaging group
- 1
- Unit
- Flasche(n)
- Composition
- Praeparatio cryodesiccata: olanzapinum 10 mg, lactosum monohydricum, acidum hydrochloridum dilutum, natrii hydroxidum, acidum tartaricum pro vitro corresp. natrium 100 µg.
Articles (1)
Zyprexa, Pulver zur Herstellung einer Injektionslösung 5 mg/ml
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
olanzapinum
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum monohydricum
|
- | Substance | HNIDK |
|
acidum hydrochloridum dilutum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum tartaricum
|
- | Substance | HNIDK |
|
natrium
|
100.0 UG | Substance | HBESI |
Reimbursement information
Public price
CHF 16.10
Specialties list
Yes
Generic
No
SL addition date:
01/03/2004
Authorization holder
Cheplapharm Schweiz GmbH
4102 Binningen
Authorization information
- Swissmedic authorization number
- 55692
- Drug name
- Zyprexa, Pulver zur Herstellung einer Injektionslösung
- Galenic form
- PULP
- ATC Code
- N05AH03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 20/12/2001
- Authorization expiration date
- 31/12/9999
- IT number
- 01.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZYPREXA subst sèche 10 mg fl
- Description (DE)
- ZYPREXA Trockensub 10 mg Fl
- Market launch
- 20/12/2001
- Narcotic (BTM)
- No